nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Sorafenib—thyroid cancer	0.312	0.386	CbGbCtD
Carbamazepine—RALBP1—Doxorubicin—thyroid cancer	0.189	0.234	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—thyroid cancer	0.071	0.0879	CbGbCtD
Carbamazepine—ABCC2—Sorafenib—thyroid cancer	0.0327	0.0405	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0218	0.027	CbGbCtD
Carbamazepine—CYP3A7—Sorafenib—thyroid cancer	0.0218	0.027	CbGbCtD
Carbamazepine—CYP2B6—Sorafenib—thyroid cancer	0.0208	0.0257	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—thyroid cancer	0.0198	0.0246	CbGbCtD
Carbamazepine—CYP3A5—Sorafenib—thyroid cancer	0.0164	0.0203	CbGbCtD
Carbamazepine—CYP2C8—Sorafenib—thyroid cancer	0.0157	0.0195	CbGbCtD
Carbamazepine—CYP2C19—Sorafenib—thyroid cancer	0.0132	0.0164	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—thyroid cancer	0.0126	0.0156	CbGbCtD
Carbamazepine—CYP1A2—Sorafenib—thyroid cancer	0.0122	0.0151	CbGbCtD
Carbamazepine—CYP2C9—Sorafenib—thyroid cancer	0.011	0.0136	CbGbCtD
Carbamazepine—ABCB1—Sorafenib—thyroid cancer	0.0107	0.0132	CbGbCtD
Carbamazepine—CYP3A4—Vandetanib—thyroid cancer	0.0106	0.0131	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—thyroid cancer	0.00646	0.00801	CbGbCtD
Carbamazepine—CYP3A4—Sorafenib—thyroid cancer	0.00638	0.00791	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—thyroid cancer	0.00387	0.0048	CbGbCtD
Carbamazepine—Nepafenac—PTGS2—thyroid cancer	0.0005	0.275	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—thyroid cancer	0.000488	0.269	CrCbGaD
Carbamazepine—Salsalate—PTGS2—thyroid cancer	0.000415	0.228	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—thyroid cancer	0.000415	0.228	CrCbGaD
Carbamazepine—Purpura—Epirubicin—thyroid cancer	0.000195	0.00107	CcSEcCtD
Carbamazepine—Vascular purpura—Doxorubicin—thyroid cancer	0.000195	0.00107	CcSEcCtD
Carbamazepine—Hepatic failure—Doxorubicin—thyroid cancer	0.000194	0.00107	CcSEcCtD
Carbamazepine—Cardiac failure—Epirubicin—thyroid cancer	0.000193	0.00106	CcSEcCtD
Carbamazepine—Lethargy—Epirubicin—thyroid cancer	0.000192	0.00106	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000192	0.00106	CcSEcCtD
Carbamazepine—Hyponatraemia—Epirubicin—thyroid cancer	0.000189	0.00104	CcSEcCtD
Carbamazepine—Osteoarthritis—Epirubicin—thyroid cancer	0.000188	0.00103	CcSEcCtD
Carbamazepine—Diplopia—Epirubicin—thyroid cancer	0.000188	0.00103	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000185	0.00101	CcSEcCtD
Carbamazepine—Hypersensitivity—Sorafenib—thyroid cancer	0.000184	0.00101	CcSEcCtD
Carbamazepine—Renal impairment—Doxorubicin—thyroid cancer	0.000183	0.00101	CcSEcCtD
Carbamazepine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000182	0.001	CcSEcCtD
Carbamazepine—Purpura—Doxorubicin—thyroid cancer	0.000181	0.000993	CcSEcCtD
Carbamazepine—Asthenia—Sorafenib—thyroid cancer	0.00018	0.000987	CcSEcCtD
Carbamazepine—Cardiac arrest—Epirubicin—thyroid cancer	0.000179	0.000984	CcSEcCtD
Carbamazepine—Cardiac failure—Doxorubicin—thyroid cancer	0.000178	0.000981	CcSEcCtD
Carbamazepine—Lethargy—Doxorubicin—thyroid cancer	0.000178	0.000977	CcSEcCtD
Carbamazepine—Pruritus—Sorafenib—thyroid cancer	0.000177	0.000974	CcSEcCtD
Carbamazepine—Ataxia—Epirubicin—thyroid cancer	0.000177	0.000973	CcSEcCtD
Carbamazepine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000175	0.000961	CcSEcCtD
Carbamazepine—Diplopia—Doxorubicin—thyroid cancer	0.000174	0.000957	CcSEcCtD
Carbamazepine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000174	0.000957	CcSEcCtD
Carbamazepine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000174	0.000955	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000172	0.000945	CcSEcCtD
Carbamazepine—Hypokalaemia—Epirubicin—thyroid cancer	0.000171	0.000942	CcSEcCtD
Carbamazepine—Diarrhoea—Sorafenib—thyroid cancer	0.000171	0.000942	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00017	0.000932	CcSEcCtD
Carbamazepine—Muscular weakness—Epirubicin—thyroid cancer	0.000166	0.000913	CcSEcCtD
Carbamazepine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000166	0.00091	CcSEcCtD
Carbamazepine—Dizziness—Sorafenib—thyroid cancer	0.000166	0.00091	CcSEcCtD
Carbamazepine—Ataxia—Doxorubicin—thyroid cancer	0.000164	0.0009	CcSEcCtD
Carbamazepine—Dysphagia—Epirubicin—thyroid cancer	0.000163	0.000894	CcSEcCtD
Carbamazepine—Eosinophilia—Epirubicin—thyroid cancer	0.000161	0.000885	CcSEcCtD
Carbamazepine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000161	0.000884	CcSEcCtD
Carbamazepine—Pancreatitis—Epirubicin—thyroid cancer	0.00016	0.000877	CcSEcCtD
Carbamazepine—Vomiting—Sorafenib—thyroid cancer	0.000159	0.000875	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000159	0.000874	CcSEcCtD
Carbamazepine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000159	0.000871	CcSEcCtD
Carbamazepine—Rash—Sorafenib—thyroid cancer	0.000158	0.000868	CcSEcCtD
Carbamazepine—Dermatitis—Sorafenib—thyroid cancer	0.000158	0.000867	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000157	0.000862	CcSEcCtD
Carbamazepine—Headache—Sorafenib—thyroid cancer	0.000157	0.000862	CcSEcCtD
Carbamazepine—Bronchitis—Epirubicin—thyroid cancer	0.000156	0.00086	CcSEcCtD
Carbamazepine—Pancytopenia—Epirubicin—thyroid cancer	0.000155	0.000849	CcSEcCtD
Carbamazepine—Muscular weakness—Doxorubicin—thyroid cancer	0.000154	0.000844	CcSEcCtD
Carbamazepine—Dysphagia—Doxorubicin—thyroid cancer	0.000151	0.000828	CcSEcCtD
Carbamazepine—Pollakiuria—Epirubicin—thyroid cancer	0.00015	0.000826	CcSEcCtD
Carbamazepine—Eosinophilia—Doxorubicin—thyroid cancer	0.000149	0.000819	CcSEcCtD
Carbamazepine—Nausea—Sorafenib—thyroid cancer	0.000149	0.000817	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000149	0.000816	CcSEcCtD
Carbamazepine—Weight increased—Epirubicin—thyroid cancer	0.000148	0.000814	CcSEcCtD
Carbamazepine—Pancreatitis—Doxorubicin—thyroid cancer	0.000148	0.000811	CcSEcCtD
Carbamazepine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000147	0.000807	CcSEcCtD
Carbamazepine—Pneumonia—Epirubicin—thyroid cancer	0.000146	0.000802	CcSEcCtD
Carbamazepine—Infestation NOS—Epirubicin—thyroid cancer	0.000145	0.000797	CcSEcCtD
Carbamazepine—Drowsiness—Epirubicin—thyroid cancer	0.000145	0.000797	CcSEcCtD
Carbamazepine—Infestation—Epirubicin—thyroid cancer	0.000145	0.000797	CcSEcCtD
Carbamazepine—Bronchitis—Doxorubicin—thyroid cancer	0.000145	0.000796	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000144	0.000791	CcSEcCtD
Carbamazepine—Pancytopenia—Doxorubicin—thyroid cancer	0.000143	0.000786	CcSEcCtD
Carbamazepine—Renal failure—Epirubicin—thyroid cancer	0.000143	0.000784	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000142	0.000782	CcSEcCtD
Carbamazepine—Jaundice—Epirubicin—thyroid cancer	0.000141	0.000777	CcSEcCtD
Carbamazepine—Stomatitis—Epirubicin—thyroid cancer	0.000141	0.000777	CcSEcCtD
Carbamazepine—Conjunctivitis—Epirubicin—thyroid cancer	0.000141	0.000775	CcSEcCtD
Carbamazepine—Urinary tract infection—Epirubicin—thyroid cancer	0.000141	0.000775	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—thyroid cancer	0.000139	0.000764	CcSEcCtD
Carbamazepine—Haematuria—Epirubicin—thyroid cancer	0.000138	0.00076	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000137	0.000755	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000137	0.000754	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—thyroid cancer	0.000137	0.000753	CcSEcCtD
Carbamazepine—Sinusitis—Epirubicin—thyroid cancer	0.000136	0.000748	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000136	0.000746	CcSEcCtD
Carbamazepine—Agranulocytosis—Epirubicin—thyroid cancer	0.000135	0.000744	CcSEcCtD
Carbamazepine—Pneumonia—Doxorubicin—thyroid cancer	0.000135	0.000742	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—thyroid cancer	0.000134	0.000738	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—thyroid cancer	0.000134	0.000738	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—thyroid cancer	0.000134	0.000738	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000133	0.000731	CcSEcCtD
Carbamazepine—Bradycardia—Epirubicin—thyroid cancer	0.000133	0.000729	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—thyroid cancer	0.000132	0.000725	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000132	0.000723	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—thyroid cancer	0.000131	0.000719	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—thyroid cancer	0.000131	0.000719	CcSEcCtD
Carbamazepine—Rhinitis—Epirubicin—thyroid cancer	0.000131	0.000718	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00013	0.000717	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00013	0.000717	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—thyroid cancer	0.00013	0.000716	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—thyroid cancer	0.000129	0.00071	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000129	0.000707	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—thyroid cancer	0.000128	0.000705	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—thyroid cancer	0.000128	0.000703	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000128	0.000703	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—thyroid cancer	0.000128	0.000702	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000127	0.000698	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—thyroid cancer	0.000126	0.000692	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000125	0.000689	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—thyroid cancer	0.000123	0.000677	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—thyroid cancer	0.000123	0.000674	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—thyroid cancer	0.000122	0.000669	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—thyroid cancer	0.000121	0.000667	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—thyroid cancer	0.000121	0.000664	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—thyroid cancer	0.000121	0.000664	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—thyroid cancer	0.000121	0.000664	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—thyroid cancer	0.00012	0.000662	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—thyroid cancer	0.00012	0.000657	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000119	0.000654	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000119	0.000652	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000118	0.000651	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—thyroid cancer	0.000118	0.000649	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—thyroid cancer	0.000118	0.000649	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—thyroid cancer	0.000118	0.000647	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000117	0.000645	CcSEcCtD
Carbamazepine—Chills—Epirubicin—thyroid cancer	0.000117	0.000642	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—thyroid cancer	0.000116	0.000639	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—thyroid cancer	0.000115	0.000633	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—thyroid cancer	0.000114	0.000627	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000114	0.000626	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—thyroid cancer	0.000113	0.000623	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—thyroid cancer	0.000113	0.000623	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—thyroid cancer	0.000113	0.000619	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—thyroid cancer	0.000112	0.000618	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000112	0.000615	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—thyroid cancer	0.000112	0.000615	CcSEcCtD
Carbamazepine—Tension—Epirubicin—thyroid cancer	0.000111	0.000612	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—thyroid cancer	0.000111	0.00061	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—thyroid cancer	0.00011	0.000605	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—thyroid cancer	0.00011	0.000603	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—thyroid cancer	0.000109	0.000601	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—thyroid cancer	0.000109	0.000599	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—thyroid cancer	0.000109	0.000598	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000109	0.000597	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—thyroid cancer	0.000108	0.000594	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—thyroid cancer	0.000108	0.000592	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—thyroid cancer	0.000107	0.000587	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—thyroid cancer	0.000106	0.000585	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—thyroid cancer	0.000106	0.00058	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—thyroid cancer	0.000105	0.000577	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—thyroid cancer	0.000105	0.000577	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—thyroid cancer	0.000105	0.000576	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—thyroid cancer	0.000104	0.000573	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—thyroid cancer	0.000103	0.000566	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—thyroid cancer	0.000103	0.000565	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—thyroid cancer	0.000102	0.00056	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—thyroid cancer	0.000102	0.00056	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—thyroid cancer	0.000102	0.000559	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—thyroid cancer	0.000101	0.000558	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—thyroid cancer	0.000101	0.000558	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—thyroid cancer	0.000101	0.000554	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—thyroid cancer	9.96e-05	0.000548	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—thyroid cancer	9.89e-05	0.000543	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—thyroid cancer	9.82e-05	0.00054	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—thyroid cancer	9.79e-05	0.000538	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—thyroid cancer	9.69e-05	0.000533	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—thyroid cancer	9.65e-05	0.000531	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—thyroid cancer	9.65e-05	0.000531	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—thyroid cancer	9.65e-05	0.000531	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—thyroid cancer	9.64e-05	0.00053	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—thyroid cancer	9.62e-05	0.000529	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	9.58e-05	0.000527	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—thyroid cancer	9.44e-05	0.000519	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—thyroid cancer	9.42e-05	0.000518	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—thyroid cancer	9.41e-05	0.000517	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—thyroid cancer	9.39e-05	0.000516	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—thyroid cancer	9.33e-05	0.000513	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—thyroid cancer	9.25e-05	0.000509	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—thyroid cancer	9.25e-05	0.000509	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—thyroid cancer	9.22e-05	0.000507	CcSEcCtD
Carbamazepine—Infection—Epirubicin—thyroid cancer	9.19e-05	0.000505	CcSEcCtD
Carbamazepine—Shock—Epirubicin—thyroid cancer	9.1e-05	0.0005	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—thyroid cancer	9.09e-05	0.0005	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—thyroid cancer	9.07e-05	0.000499	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—thyroid cancer	9.06e-05	0.000498	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—thyroid cancer	9.06e-05	0.000498	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—thyroid cancer	9.03e-05	0.000496	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—thyroid cancer	8.99e-05	0.000494	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—thyroid cancer	8.94e-05	0.000492	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—thyroid cancer	8.93e-05	0.000491	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—thyroid cancer	8.93e-05	0.000491	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—thyroid cancer	8.93e-05	0.000491	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—thyroid cancer	8.9e-05	0.000489	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	8.87e-05	0.000488	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—thyroid cancer	8.82e-05	0.000485	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—thyroid cancer	8.73e-05	0.00048	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—thyroid cancer	8.65e-05	0.000475	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—thyroid cancer	8.63e-05	0.000474	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—thyroid cancer	8.56e-05	0.000471	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—thyroid cancer	8.56e-05	0.000471	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—thyroid cancer	8.5e-05	0.000468	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	8.43e-05	0.000463	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—thyroid cancer	8.42e-05	0.000463	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—thyroid cancer	8.4e-05	0.000461	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—thyroid cancer	8.38e-05	0.000461	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—thyroid cancer	8.37e-05	0.00046	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—thyroid cancer	8.36e-05	0.000459	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—thyroid cancer	8.32e-05	0.000457	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—thyroid cancer	8.31e-05	0.000457	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—thyroid cancer	8.28e-05	0.000455	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—thyroid cancer	8.25e-05	0.000453	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—thyroid cancer	8.23e-05	0.000452	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—thyroid cancer	8.16e-05	0.000449	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—thyroid cancer	8.14e-05	0.000448	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—thyroid cancer	8.04e-05	0.000442	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—thyroid cancer	8e-05	0.00044	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—thyroid cancer	7.99e-05	0.000439	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—thyroid cancer	7.98e-05	0.000438	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—thyroid cancer	7.91e-05	0.000435	CcSEcCtD
Carbamazepine—Pain—Epirubicin—thyroid cancer	7.91e-05	0.000435	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	7.8e-05	0.000429	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—thyroid cancer	7.74e-05	0.000426	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—thyroid cancer	7.69e-05	0.000423	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—thyroid cancer	7.63e-05	0.00042	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—thyroid cancer	7.62e-05	0.000419	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—thyroid cancer	7.61e-05	0.000418	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—thyroid cancer	7.57e-05	0.000416	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—thyroid cancer	7.54e-05	0.000414	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—thyroid cancer	7.44e-05	0.000409	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	7.39e-05	0.000406	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—thyroid cancer	7.38e-05	0.000406	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—thyroid cancer	7.35e-05	0.000404	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—thyroid cancer	7.32e-05	0.000402	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—thyroid cancer	7.32e-05	0.000402	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—thyroid cancer	7.31e-05	0.000402	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—thyroid cancer	7.31e-05	0.000402	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—thyroid cancer	7.05e-05	0.000388	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—thyroid cancer	7e-05	0.000385	CcSEcCtD
Carbamazepine—Hypersensitivity—Epirubicin—thyroid cancer	6.82e-05	0.000375	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—thyroid cancer	6.8e-05	0.000374	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—thyroid cancer	6.77e-05	0.000372	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—thyroid cancer	6.77e-05	0.000372	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—thyroid cancer	6.64e-05	0.000365	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—thyroid cancer	6.55e-05	0.00036	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—thyroid cancer	6.33e-05	0.000348	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—thyroid cancer	6.31e-05	0.000347	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—thyroid cancer	6.14e-05	0.000338	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—thyroid cancer	6.12e-05	0.000336	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—thyroid cancer	6.06e-05	0.000333	CcSEcCtD
Carbamazepine—Vomiting—Epirubicin—thyroid cancer	5.88e-05	0.000323	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—thyroid cancer	5.86e-05	0.000322	CcSEcCtD
Carbamazepine—Rash—Epirubicin—thyroid cancer	5.83e-05	0.000321	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—thyroid cancer	5.83e-05	0.00032	CcSEcCtD
Carbamazepine—Headache—Epirubicin—thyroid cancer	5.8e-05	0.000319	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—thyroid cancer	5.66e-05	0.000311	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—thyroid cancer	5.5e-05	0.000302	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—thyroid cancer	5.44e-05	0.000299	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—thyroid cancer	5.4e-05	0.000297	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—thyroid cancer	5.39e-05	0.000296	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—thyroid cancer	5.36e-05	0.000295	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—thyroid cancer	5.08e-05	0.00028	CcSEcCtD
Carbamazepine—UGT2B7—NRF2 pathway—NRG1—thyroid cancer	4.66e-05	0.00529	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	4.53e-05	0.00514	CbGpPWpGaD
Carbamazepine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.49e-05	0.0051	CbGpPWpGaD
Carbamazepine—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.39e-05	0.00499	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	4.28e-05	0.00486	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—RXRA—thyroid cancer	4.27e-05	0.00485	CbGpPWpGaD
Carbamazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.19e-05	0.00476	CbGpPWpGaD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	4.16e-05	0.00473	CbGpPWpGaD
Carbamazepine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.07e-05	0.00462	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TCF7L1—thyroid cancer	4.03e-05	0.00458	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CDK1—thyroid cancer	3.96e-05	0.0045	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	3.85e-05	0.00437	CbGpPWpGaD
Carbamazepine—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.82e-05	0.00434	CbGpPWpGaD
Carbamazepine—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.8e-05	0.00432	CbGpPWpGaD
Carbamazepine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.8e-05	0.00432	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—NRG1—thyroid cancer	3.69e-05	0.00419	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—RXRA—thyroid cancer	3.68e-05	0.00418	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	3.67e-05	0.00417	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CDK1—thyroid cancer	3.64e-05	0.00414	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—MINPP1—thyroid cancer	3.47e-05	0.00394	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—CDK1—thyroid cancer	3.46e-05	0.00393	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	3.4e-05	0.00386	CbGpPWpGaD
Carbamazepine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.4e-05	0.00386	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—RXRA—thyroid cancer	3.38e-05	0.00384	CbGpPWpGaD
Carbamazepine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.26e-05	0.00371	CbGpPWpGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.25e-05	0.00369	CbGpPWpGaD
Carbamazepine—CYP3A7—Biological oxidations—RXRA—thyroid cancer	3.23e-05	0.00367	CbGpPWpGaD
Carbamazepine—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.1e-05	0.00352	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NDUFA13—thyroid cancer	2.95e-05	0.00335	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TSHR—thyroid cancer	2.95e-05	0.00335	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	2.94e-05	0.00334	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PRKAR1A—thyroid cancer	2.9e-05	0.0033	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	2.81e-05	0.0032	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CHST14—thyroid cancer	2.77e-05	0.00315	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MEN1—thyroid cancer	2.77e-05	0.00315	CbGpPWpGaD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.7e-05	0.00306	CbGpPWpGaD
Carbamazepine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.65e-05	0.00301	CbGpPWpGaD
Carbamazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.52e-05	0.00286	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTCH1—thyroid cancer	2.51e-05	0.00285	CbGpPWpGaD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	2.51e-05	0.00285	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CDK1—thyroid cancer	2.47e-05	0.0028	CbGpPWpGaD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.41e-05	0.00273	CbGpPWpGaD
Carbamazepine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	2.39e-05	0.00271	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MINPP1—thyroid cancer	2.37e-05	0.00269	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—RXRA—thyroid cancer	2.33e-05	0.00265	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—PPARG—thyroid cancer	2.32e-05	0.00264	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SST—thyroid cancer	2.29e-05	0.00261	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—RXRA—thyroid cancer	2.29e-05	0.0026	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—HPGD—thyroid cancer	2.24e-05	0.00254	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CALCA—thyroid cancer	2.21e-05	0.00251	CbGpPWpGaD
Carbamazepine—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.19e-05	0.00249	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	2.17e-05	0.00247	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.17e-05	0.00247	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.15e-05	0.00244	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.14e-05	0.00243	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—PPARG—thyroid cancer	2.13e-05	0.00242	CbGpPWpGaD
Carbamazepine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.04e-05	0.00232	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—RXRA—thyroid cancer	2.02e-05	0.0023	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NDUFA13—thyroid cancer	2.02e-05	0.00229	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	2e-05	0.00228	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CDK1—thyroid cancer	2e-05	0.00227	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—NRAS—thyroid cancer	1.99e-05	0.00226	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.92e-05	0.00218	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CHST14—thyroid cancer	1.9e-05	0.00215	CbGpPWpGaD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.88e-05	0.00213	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—NRAS—thyroid cancer	1.83e-05	0.00208	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	1.8e-05	0.00205	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MINPP1—thyroid cancer	1.75e-05	0.00199	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.75e-05	0.00199	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.71e-05	0.00195	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—KRAS—thyroid cancer	1.71e-05	0.00195	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	1.64e-05	0.00187	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.63e-05	0.00185	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.62e-05	0.00184	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRG1—thyroid cancer	1.6e-05	0.00182	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—KRAS—thyroid cancer	1.57e-05	0.00179	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.56e-05	0.00177	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—HPGD—thyroid cancer	1.53e-05	0.00174	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.49e-05	0.0017	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	1.49e-05	0.00169	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MINPP1—thyroid cancer	1.48e-05	0.00169	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.46e-05	0.00166	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—thyroid cancer	1.46e-05	0.00165	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—PPARG—thyroid cancer	1.45e-05	0.00164	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TERT—thyroid cancer	1.44e-05	0.00164	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—NRAS—thyroid cancer	1.42e-05	0.00161	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	1.41e-05	0.0016	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CHST14—thyroid cancer	1.4e-05	0.00159	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HIF1A—thyroid cancer	1.38e-05	0.00156	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CHST14—thyroid cancer	1.37e-05	0.00156	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.37e-05	0.00155	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	1.34e-05	0.00153	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—thyroid cancer	1.34e-05	0.00152	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MINPP1—thyroid cancer	1.33e-05	0.00151	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NRAS—thyroid cancer	1.31e-05	0.00148	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MINPP1—thyroid cancer	1.29e-05	0.00147	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—TPR—thyroid cancer	1.28e-05	0.00146	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	1.26e-05	0.00144	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	1.26e-05	0.00143	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NRAS—thyroid cancer	1.24e-05	0.00141	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—KRAS—thyroid cancer	1.22e-05	0.00139	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MINPP1—thyroid cancer	1.21e-05	0.00137	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CHST14—thyroid cancer	1.19e-05	0.00135	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.14e-05	0.0013	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BRAF—thyroid cancer	1.14e-05	0.0013	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HPGD—thyroid cancer	1.13e-05	0.00128	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	1.13e-05	0.00128	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—KRAS—thyroid cancer	1.12e-05	0.00128	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HPGD—thyroid cancer	1.1e-05	0.00125	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.1e-05	0.00125	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.08e-05	0.00123	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—KRAS—thyroid cancer	1.07e-05	0.00121	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CHST14—thyroid cancer	1.06e-05	0.0012	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—thyroid cancer	1.04e-05	0.00118	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CHST14—thyroid cancer	1.03e-05	0.00117	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MINPP1—thyroid cancer	1.03e-05	0.00117	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.03e-05	0.00117	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.02e-05	0.00116	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.02e-05	0.00116	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.01e-05	0.00114	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CHST14—thyroid cancer	9.66e-06	0.0011	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—SLC5A5—thyroid cancer	9.61e-06	0.00109	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HPGD—thyroid cancer	9.57e-06	0.00109	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—thyroid cancer	9.55e-06	0.00109	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	9.46e-06	0.00107	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—AKT1—thyroid cancer	9.18e-06	0.00104	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—thyroid cancer	9.08e-06	0.00103	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NRAS—thyroid cancer	8.85e-06	0.00101	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	8.78e-06	0.000997	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TPR—thyroid cancer	8.78e-06	0.000997	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	8.63e-06	0.000981	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HPGD—thyroid cancer	8.54e-06	0.00097	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—AKT1—thyroid cancer	8.43e-06	0.000958	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HPGD—thyroid cancer	8.33e-06	0.000947	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCND1—thyroid cancer	8.32e-06	0.000946	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CHST14—thyroid cancer	8.25e-06	0.000938	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—RXRA—thyroid cancer	8.08e-06	0.000918	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	8.04e-06	0.000914	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTEN—thyroid cancer	8.03e-06	0.000913	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MINPP1—thyroid cancer	7.97e-06	0.000905	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HPGD—thyroid cancer	7.79e-06	0.000885	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.76e-06	0.000882	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.65e-06	0.000869	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KRAS—thyroid cancer	7.62e-06	0.000866	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.27e-06	0.000825	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRAS—thyroid cancer	7.17e-06	0.000814	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.01e-06	0.000797	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.93e-06	0.000787	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	6.78e-06	0.00077	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HPGD—thyroid cancer	6.65e-06	0.000756	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	6.57e-06	0.000746	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TPR—thyroid cancer	6.49e-06	0.000737	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—thyroid cancer	6.48e-06	0.000736	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.43e-06	0.00073	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	6.39e-06	0.000725	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CHST14—thyroid cancer	6.37e-06	0.000724	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TPR—thyroid cancer	6.34e-06	0.000721	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.32e-06	0.000717	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	6.24e-06	0.000709	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—thyroid cancer	6.17e-06	0.000701	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—thyroid cancer	5.72e-06	0.00065	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—RXRA—thyroid cancer	5.52e-06	0.000627	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TPR—thyroid cancer	5.49e-06	0.000624	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—thyroid cancer	5.48e-06	0.000623	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	5.41e-06	0.000614	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.4e-06	0.000613	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.38e-06	0.000612	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—thyroid cancer	5.24e-06	0.000596	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HPGD—thyroid cancer	5.13e-06	0.000583	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—thyroid cancer	5.1e-06	0.000579	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TPR—thyroid cancer	4.9e-06	0.000557	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.9e-06	0.000557	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	4.86e-06	0.000552	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	4.83e-06	0.000548	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TPR—thyroid cancer	4.79e-06	0.000544	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.79e-06	0.000544	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	4.75e-06	0.000539	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	4.71e-06	0.000535	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—thyroid cancer	4.63e-06	0.000526	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TPR—thyroid cancer	4.47e-06	0.000508	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	4.4e-06	0.0005	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.37e-06	0.000497	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	4.11e-06	0.000467	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—RXRA—thyroid cancer	4.08e-06	0.000464	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.04e-06	0.000459	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—thyroid cancer	4.01e-06	0.000456	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—RXRA—thyroid cancer	3.99e-06	0.000453	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.99e-06	0.000453	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.85e-06	0.000438	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TPR—thyroid cancer	3.82e-06	0.000434	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.76e-06	0.000427	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.67e-06	0.000417	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.58e-06	0.000407	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—thyroid cancer	3.5e-06	0.000397	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—thyroid cancer	3.49e-06	0.000396	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—RXRA—thyroid cancer	3.46e-06	0.000393	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.44e-06	0.000391	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.41e-06	0.000387	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.36e-06	0.000382	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	3.35e-06	0.00038	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.14e-06	0.000356	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—RXRA—thyroid cancer	3.08e-06	0.00035	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—RXRA—thyroid cancer	3.01e-06	0.000342	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3e-06	0.000341	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TPR—thyroid cancer	2.95e-06	0.000335	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.9e-06	0.00033	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.86e-06	0.000325	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—RXRA—thyroid cancer	2.81e-06	0.00032	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—thyroid cancer	2.74e-06	0.000311	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.74e-06	0.000311	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.68e-06	0.000305	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—thyroid cancer	2.58e-06	0.000293	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—thyroid cancer	2.52e-06	0.000286	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—RXRA—thyroid cancer	2.4e-06	0.000273	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—thyroid cancer	2.39e-06	0.000272	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.34e-06	0.000266	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.21e-06	0.000251	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—thyroid cancer	2.18e-06	0.000248	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—thyroid cancer	2.03e-06	0.00023	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—thyroid cancer	2.02e-06	0.000229	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.98e-06	0.000225	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.95e-06	0.000221	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—thyroid cancer	1.9e-06	0.000216	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.85e-06	0.000211	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.78e-06	0.000202	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.77e-06	0.000201	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—thyroid cancer	1.73e-06	0.000196	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.72e-06	0.000195	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.53e-06	0.000174	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.52e-06	0.000172	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—thyroid cancer	1.5e-06	0.00017	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.5e-06	0.00017	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.4e-06	0.000159	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—thyroid cancer	1.38e-06	0.000157	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—thyroid cancer	1.34e-06	0.000152	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—thyroid cancer	1.3e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—thyroid cancer	1.22e-06	0.000138	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.19e-06	0.000136	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.17e-06	0.000133	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—thyroid cancer	1.04e-06	0.000118	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—thyroid cancer	1.02e-06	0.000116	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—thyroid cancer	9.96e-07	0.000113	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.21e-07	0.000105	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—thyroid cancer	8.63e-07	9.8e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—thyroid cancer	8.03e-07	9.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—thyroid cancer	7.7e-07	8.75e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—thyroid cancer	7.52e-07	8.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—thyroid cancer	7.02e-07	7.98e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—thyroid cancer	6e-07	6.82e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—thyroid cancer	4.63e-07	5.26e-05	CbGpPWpGaD
